top
Search terms
Results 1 - 10 of 10 - ordered by :
Ehjournal

There were no procedural deaths or major complications, albeit in a small number of transfemoral patients (just 15).1 The subsequent SAPIEN 3 EU trial expanded this experience to 150 patients in ...

European Heart Journal, Webb, John G., Attinger-Toller, Adrian

Date : 21/09/2017 Item size : 158345 bytes
Escardio

Transcatheter aortic valve implantation (TAVI) is safe and effective in nonagenarians, according to research presented at ESC Congress today.1 The observational study found that nonagenarians who ...

Date : 28/08/2017
ESC365

Frailty as a predictor for all-cause mortality in patients 12 months after transcatheter aortic valve implantation (TAVI)

Date : 08/04/2017
Revistaespanola

To the Editor, Transcatheter aortic valve implantation (TAVI) is a technique that was first introduced more than 10 years ago and has since become established as an alternative to surgery in the ...

Revista Española de Cardiología

Date : 01/03/2017 Item size : 41321 bytes
Revistaespanola

Identifying patients at high, or even prohibitive risk, in whom the procedure may be futile, is likely to have important implications for patient selection.1 Several scores have been used for risk ...

Revista Española de Cardiología

Date : 01/03/2017 Item size : 100969 bytes
Ehjournal

Preamble A large number of studies addressing various aspects of the diagnosis and treatment of valvular heart disease (VHD) have been published since the ESC Annual congress in 2015. Figure 1 UK ...

European Heart Journal, Alfieri, Ottavio, Vahanian, Alec

Date : 01/03/2017 Item size : 299317 bytes
Ehjournal

Abstract Aims In view of the currently available evidence from randomized trials, we aimed to compare the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) vs. surgical ...

European Heart Journal, Fasttrack Clinical, George C.M. Siontis, Fabien Praz, Thomas Pilgrim, Dimitris Mavridis, Subodh Verma, Georgia Salanti, Lars Søndergaard, Peter Jüni, Stephan Windecker

Date : 14/12/2016 Item size : 401057 bytes
Ehjournal

For the primary outcome of death from any cause, TAVI when compared with SAVR was associated with a significant 13% relative risk reduction [hazard ratio (95% CI): 0.87 (0.760.99); P = 0.038] with ...

European Heart Journal, Siontis, George C.M., Praz, Fabien, Pilgrim, Thomas, Mavridis, Dimitris, Verma, Subodh, Salanti, Georgia, Søndergaard, Lars, Jüni, Peter, Windecker, Stephan

Date : 14/12/2016 Item size : 395724 bytes
Ehjournal

For the primary outcome of death from any cause, TAVI when compared with SAVR was associated with a significant 13% relative risk reduction [hazard ratio (95% CI): 0.87 (0.760.99); P = 0.038] with ...

European Heart Journal, Siontis, George C.M., Praz, Fabien, Pilgrim, Thomas, Mavridis, Dimitris, Verma, Subodh, Salanti, Georgia, Søndergaard, Lars, Jüni, Peter, Windecker, Stephan

Date : 14/12/2016 Item size : 444615 bytes
Revistaespanola

RISK-BASED INDICATIONS In the American Heart Association/American College of Cardiology and European guidelines,3, 4 TAVI is a class I indication for symptomatic patients with severe AS who are not ...

Revista Española de Cardiología

Date : 01/12/2016 Item size : 58008 bytes